Stock Details
3349.T is COSMOS Pharmaceutical Corporation's stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 14,490.40๏ฟฅ. Average daily volumn in 3 months 167.02k. Market cap 568.24B



Stock symbol : 3349.T. Exchange : Tokyo. Currency : JPY
Lastest price : 14,350.00๏ฟฅ. Total volume : 153.20k. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

COSMOS Pharmaceutical Corporation (3349.T)
Last Price
14,350.00๏ฟฅ
Change
100.00
Volume
153.20k

Previous Close14,250.00
Open14,240.00
Day Range14,240.00-14,540.00
Bid14,310.00 x N/A
Ask14,360.00 x N/A
Volume153.2k
Average Volume167.02k
Market Cap568.24B
Beta0.28
52 Week Range10,770.00-19,630.00
Trailing P/E24.54
Foward P/E22.06
Dividend (Yield %)0.59%
Ex-Dividend Date2022-11-29



Financial Details


According to COSMOS Pharmaceutical Corporation's financial reports the company's revenue in 2022 were 755.41B an increase( +3.99%) over the years 2021 revenue that were of 726.42B. In 2022 the company's total earnings were 23.16B while total earnings in 2021 were 27.16B(-14.81%).


Loading ...



Organization

COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. As of May 31, 2022, the company operated 1,244 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was incorporated in 1983 and is headquartered in Fukuoka, Japan.

Market Cap:
568.24B
Revenue:
755.41B
Total Assets:
363.05B
Total Cash:
37.36B


News about "COSMOS Pharmaceutical Corporation"

Cosmos Pharmaceutical Corp

Source from : Reuters - 5 days ago

Reuters, the news and media division of Thomson Reuters, is the worldโ€™s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...See details»


Cosmo Pharmaceuticals NV

Source from : Reuters - 5 days ago

Cosmo Pharmaceuticals N.V. is a pharmaceutical company. The Company is focused on gastroenterology and dermatology. It develops and manufactures products, which are distributed globally.See details»


COSMOS Pharmaceutical Stock (OTC:CSMYF), Guidance and Forecast

Source from : Benzinga.com - 8 days ago

so investors have a sense of how much money a company will make in a future period. There have been no specific sales or earnings guidance reported for COSMOS Pharmaceutical in recent months.See details»


cosmos-health-signs-an-agreement-with-virax-biolabs-to-distribute-monkeypox-virus-real-time-pcr-detections-kits-in-europe-image

Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe

Source from : YAHOO!Finance - 10 days ago

Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical ...See details»


cosmos-health-signs-another-distribution-deal-expedites-sales-reach-into-german-and-austrian-markets-cosm-image

Cosmos Health Signs Another Distribution Deal; Expedites Sales Reach Into German And Austrian Markets ($COSM)

Source from : Daily Herald - 12 days ago

Cosmos Health (NASDAQ: COSM), formerly Cosmos Holdings, is decoupling from the weakness and is doing so on merit, not hype. In fact, its recent 28% surge to $0.46 in September is supported by another ...See details»


Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

Source from : YAHOO!Finance - 4 days ago

Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical ...See details»


Cosmo Pharmaceuticals Stock (OTC:CMOPF), Earnings Estimates, EPS, and Revenue

Source from : Benzinga.com - 8 days ago

Cosmo Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports ...See details»


Budesonide Inhaler Market Analysis By Growth, Emerging Trends And Future Opportunities Till 2028

Source from : MarketWatch - 10 days ago

The business intelligence report latest study, due to COVID-19 pandemic, the global Budesonide Inhaler market size is estimated to be worth US$ 4616.4 million in 2021 and is forecast to a readjusted ...See details»


open-cosmos-unveils-openconstellation-shared-space-infrastructure-image

Open Cosmos unveils OpenConstellation, shared space infrastructure

Source from : SpaceNews - 10 days ago

British small satellite startup Open Cosmos announced plans Sept. 21 for OpenConstellation, shared space infrastructure designed to offer partners access to satellite data.See details»


Polypropylene Cast Film Market Qualitative Future Analysis Of Long Term Leading That Will Change In Coming Future 2022-2029

Source from : MarketWatch - 11 days ago

The global Polypropylene Cast Film Market is likely to experience dynamic growth in the forthcoming years as a result ...See details»


the-sandbox-invests-in-cosmo-media-labs-partners-with-faze-clan-image

The Sandbox invests in Cosmo Media Labs, partners with FaZe Clan

Source from : VentureBeat - 16 days ago

The Sandbox today announced its new investment and partnership, with Cosmo Media Labs and FaZe Clan respectively.See details»


McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health

Source from : Joplin Globe - 2 days ago

McKesson Corporation (NYSE: MCK) today announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty ...See details»


chemical-distribution-global-market-report-2022-image

Chemical Distribution Global Market Report 2022

Source from : Yahoo Finance - 10 days ago

Major players in the chemical distribution market are Univar, Helm, Brenntag, Azelis Holdings, Omya, Biesterfeld, Safic-Alcan, Stockmeier, REDA Chemicals, Ashland, BASF, Jebsen & Jessen, Quimidroga, ...See details»


COSMOS Pharmaceutical Corp.

Source from : Wall Street Journal - 1 month ago

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...See details»